What Clinicians Should Know About Johnson & Johnson Janssen COVID-19 Vaccine

This COCA Call will give clinicians an overview of the J&J Janssen COVID-19 vaccine. Clinicians will learn about vaccine characteristics and administration, vaccinating special populations, and contraindications. They will also get answers to a number of clinical questions CDC has received about this new vaccine.

Comments on this video are allowed in accordance with our comment policy:
http://www.cdc.gov/SocialMedia/Tools/CommentPolicy.html

This video can also be viewed at

Recommend0 recommendationsPublished in US National Health Agency Sources

Related Articles

5 Essential Frameworks for Preventing Violent Child Death

The U.S. has a violent child death problem. Developing strategies to prevent violent child deaths death from firearms and traffic crashes is a demanding task that requires consideration of numerous upstream, interrelated, and tangential issues. To help safety advocates develop strategies to prevent violent child death, we compiled five frameworks to help: Understand and explain …
The post 5 Essential Frameworks for Preventing Violent Child Death appeared first on Salud America.

Responses